Glioblastoma Clinical Trials

78 studies are recruiting for glioblastoma in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

New York, New York 18 Boston, Massachusetts 17 Houston, Texas 13 San Francisco, California 11 Los Angeles, California 10 Miami, Florida 9 Chicago, Illinois 8 Philadelphia, Pennsylvania 8 Aurora, Colorado 7 Cleveland, Ohio 7 Columbus, Ohio 7 Durham, North Carolina 7 Rochester, Minnesota 7 Baltimore, Maryland 6 Salt Lake City, Utah 6 Seattle, Washington 6 St Louis, Missouri 6 Washington D.C., District of Columbia 6 Atlanta, Georgia 5 Cincinnati, Ohio 5 Jacksonville, Florida 5 Pittsburgh, Pennsylvania 5 Providence, Rhode Island 5 Tampa, Florida 5 Ann Arbor, Michigan 4 Birmingham, Alabama 4 Dallas, Texas 4 Minneapolis, Minnesota 4 Bethesda, Maryland 3 Buffalo, New York 3 Charlottesville, Virginia 3 Detroit, Michigan 3 Duarte, California 3 Fairfax, Virginia 3 Iowa City, Iowa 3 Nashville, Tennessee 3 Omaha, Nebraska 3 Phoenix, Arizona 3

Studies, page 4

  1. The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

    Resection of glioblastoma in or near functional brain tissue is challenging because of the proximity of important structures to the tumor site. To pursue maximal resection in a safe manner, mapping methods have been developed to test for motor and language function during the operation. Previous ev…

    Stage
    Not phased
    Ages
    Up to 90
    Site
    University of California, San Francisco, San Francisco, California
    Locations
    8 in total
    Run by
    Erasmus Medical Center

    See if you can join NCT06273176 on ClinicalTrials.gov

  2. The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

    There are no guidelines or prospective studies defining the optimal surgical treatment for gliomas of older patients (≥70 years) or those with limited functioning performance at presentation (KPS ≤70). Therefore, the decision between resection and biopsy is varied, amongst neurosurgeons internation…

    Stage
    Not phased
    Ages
    18 to 90
    Site
    University of California, San Francisco, San Francisco, California
    Locations
    8 in total
    Run by
    Jasper Gerritsen

    See if you can join NCT06146725 on ClinicalTrials.gov

  3. The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)

    There is no consensus on the optimal treatment of patients with high-grade glioma, especially when patients have limited functioning performance at presentation (KPS ≤70). Therefore, there are varied practice patterns around pursuing biopsy, resection, or palliation (best supportive care). This stu…

    Stage
    Not phased
    Ages
    18 to 90
    Site
    University of California, San Francisco, San Francisco, California
    Locations
    8 in total
    Run by
    Jasper Gerritsen

    See if you can join NCT06146738 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.